Jeffrey A. Meckler, Director at Cocrystal Pharma, Inc. (COCP), bought 163,043 shares at $0.92 ($150K) on 2015-03-25, disclosed to the SEC on 2015-03-27.
Open-market purchase of $150k COCP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| TVTX | SELL | 2024-09-30 | $562K | — | Filing → |
| INDP | BUY | 2022-11-22 | $19K | — | Filing → |
| INDP | BUY | 2022-09-12 | $29K | — | Filing → |